Flesh-Eating Zombie Drug Hits Midwest (Still Not a Joke)

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Last month, krokodil, a highly addictive drug that eats through human skin, made its first known appearance in the United States, with two cases reported in Arizona. Now, use of krokodil—which has been nicknamed the “zombie drug“—has spread to the Midwest. The Herald-News reports that five people have been treated for symptoms associated with krokodil use at the Provena Saint Joseph Medical Center in Joliet, Illinois, which is located about 40 miles from the Windy City.

Dr. Abhin Singla, director of addiction services at the Joliet hospital, told CBS 2 that one of the patients was a 25-year-old longterm heroin user who started using krokodil about a month ago. Singla notes, “When she came in, she had the destruction that occurs because of this drug, over 70 percent of her lower body.”

As we reported last month, krokodil, which is Russian slang for Desomorphine, has a similar effect to heroin, but it is significantly cheaper and easier to make. Its main ingredients are codeine, iodine, red phosphorous, paint thinner, gasoline, and hydrochloric acid. It’s far more addictive and deadly; krokodil users tend to only live two or three years. When the drug is injected into the skin, it often causes gangrene, forcing the skin to rot away, and causes speech problems and erratic muscle movements. Singla told the Beacon-News, “If you want to kill yourself, (using) this is the way to do it.” (For gruesome and totally NSFW images of the health effects of krokodil, go here.)

Singla told the Herald-News that the krokodil users believed that they were getting heroin and were given the other drug instead. Most said they obtained the drug in Chicago—not Joliet. Three of the patients were “middle-class white women in their early to mid-20s” and the other two were men, one 22 and the other 32, with arm wounds, according to the paper. The 25-year-old remains in intensive care, and “two others have left the hospital against medical advice because they were afraid of prosecution.” Krokodil is a new synthetic drug, so it is not yet a controlled substance, according to a DEA spokesperson.

Until this fall, the drug had never been seen before in the United States. However, the drug has been prevalent in Russia. In the first few months of 2011 alone, the Russia’s Federal Drug Control Service confiscated 65 million doses of the drug.

The Drug Enforcement Agency (DEA) is not currently investigating the reported emergence of krokodil in the US. “We have not received any sort of specimen in any of our labs,” DEA spokeswoman Dawn Dearden tells Mother Jones. But, she adds, “we’re keeping an eye out on the trends across the country, and if and when we need to get involved, we certainly will.”

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with the Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with the Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate